Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: Future Cardiol. 2013 Nov;9(6):817–848. doi: 10.2217/fca.13.66

Figure 5. Competing risk analysis: outcomes in children with dilated cardiomyopathy.

Figure 5

Competing risk analysis for sudden cardiac death, nonsudden cardiac death, unknown cause of death and cardiac transplantation among 1803 children with dilated cardiomyopathy listed in the Pediatric Cardiomyopathy Registry. The 3-, 5- and 10-year cumulative incidence rates (95% CI) of sudden cardiac death are estimated to be 2.0% (1.4–2.8%), 2.4% (1.7–3.4%) and 2.7% (1.8–3.9%), respectively; of nonsudden cardiac death, 10.8% (9.3–12.4%), 12.1% (10.4–13.9%) and 14.9% (12.6–17.3%), respectively; and of heart transplantation, 27% (25–29%), 29% (27–32%) and 31% (28–34%), respectively. The rate of death of unknown cause (95% CI) was 3.4% (2.6–4.5%), 4.0% (3.0–5.2%) and 5.2 (3.6–7.3%), respectively.

DCM: Dilated cardiomyopathy.

Reproduced with permission from [22].